Adjuvant triamcinolone acetonide injections in oro-pharyngeal pemphigus vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 10, 2010, Pages 1157-1165

  Mignogna, M D ^a   Fortuna, G ^a   Leuci, S ^a   Adamo, D ^a   Dell'Aversana Orabona, G ^a   Ruoppo, E ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

oral mucosa; pemphigus vulgaris; remission; side effects; topical corticosteroids; triamcinolone acetonide

Indexed keywords

AZATHIOPRINE; CLOBETASOL; CYCLOPHOSPHAMIDE; DEFLAZACORT; FLUCONAZOLE; METHYLPREDNISOLONE; NYSTATIN; PREDNISONE; TRIACORT; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TRIAMVIRGI; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; OROPHARYNX PEMPHIGUS VULGARIS; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOUTH DISEASES; PAIN; PATIENT SATISFACTION; PEMPHIGUS; PHARYNGEAL DISEASES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; YOUNG ADULT;

EID: 77956319770     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03610.x     Document Type: Article

References (22)

1. Ioannides D, Lazaridou E, Rigopoulos D. Pemphigus. J Eur Acad Dermatol Venereol 2008 22 : 1478 1496.
2. Martin LK, Werth V, Villanueva E et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2009 : CD006263.
3. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994 77 : 598 604.
4. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005 366 : 61 73.
5. Fellner MJ, Sapadin AN. Current therapy of pemphigus vulgaris. Mt Sinai J Med 2001 68 : 268 278.
6. Lopez-Jornet P, Bermejo-Fenoll A. Treatment of pemphigus and pemphigoids. Med Oral Patol Oral Cir Bucal 2005 10 : 410 411.
7. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000 42 : 422 427.
8. Murrell DF, Dick S, Ahmed AR et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008 58 : 1043 1046.
9. Mignogna MD, Lo Muzio L, Mignogna RE et al. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. J Oral Pathol Med 2000 29 : 145 152.
10. Mimouni D, Nousari CH, Cummins DL et al. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol 2003 49 : 1059 1062.
11. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005 14 : 798 804.
12. Lozada F, Silverman S Jr. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol 1980 116 : 898 901.
13. Lozada-Nur F, Huang MZ, Zhou GA. Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1991 71 : 283 287.
14. Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 84 : 349 355.
15. Dumas V, Roujeau JC, Wolkenstein P et al. The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid. Br J Dermatol 1999 140 : 1127 1129.
16. Gooptu C, Staughton RC. Use of topical cyclosporin in oral pemphigus. J Am Acad Dermatol 1998 38 : 860 861.
17. Gach JE, Ilchyshyn A. Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. Clin Exp Dermatol 2004 29 : 271 272.
18. Hodgson TA, Malik F, Hegarty AM et al. Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris. Eur J Dermatol 2003 13 : 142 144.
19. Endo H, Rees TD, Matsue M et al. Early detection and successful management of oral pemphigus vulgaris: a case report. J Periodontol 2005 76 : 154 160.
20. Ben Lagha N, Poulesquen V, Roujeau JC et al. Pemphigus vulgaris: a case-based update. J Can Dent Assoc 2005 71 : 667 672.
21. Shumaker PR, Rao J, Goldman MP. Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration. Dermatol Surg 2005 31 : 1340 1343.
22. Shaikh S, Ho S, Engelmann LA et al. Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 2006 90 : 233 236.